Assembly Biosciences
  few hours ago at Macroaxis
Filed for Ecor1 Capital Fund Qualified Lp
Filed transaction by Assembly Biosciences Inc executive. General open market or private purchase of non-derivative or derivative security. Assembly Biosciences insider trading alert for perchase of call options by Ecor1 Capital Fund Qualified Lp, the corporate stakeholder, on September 22, 2018. This event was filed by Assembly Biosciences Inc with SEC on 2018-04-18. Statement of changes in beneficial ownership - SEC Form 4  
 perchase assembly biosciences   healthcare biotechnology pharmaceutical products
PAREXEL International
  few hours ago at Macroaxis
Filed for Gadi Saarony
Filed transaction by Parexel International Cor officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. PAREXEL International Corporation insider trading alert for exercise of stock option (right to buy) by Gadi Saarony, Corp. Sr. VP CRS, on September 22, 2018. This event was filed by Parexel International Cor with SEC on 2012-11-20. Statement of changes in beneficial ownership - SEC Form 4. Gadi Saarony is currently serves as senior vice president - clinical research services of PAREXEL International  
 exercise parexel international   healthcare pharmaceuticals and biosciences
Seattle Genetics
  few hours ago at Macroaxis
Filed for Baker Biotech Capital Gp Llc
Filed transaction by Seattle Genetics Inc director. General open market or private purchase of non-derivative or derivative security. Seattle Genetics insider trading alert for perchase of common stock by Baker Biotech Capital Gp Llc, the corporate stakeholder, on September 22, 2018. This event was filed by Seattle Genetics Inc with SEC on 2006-05-25. Statement of changes in beneficial ownership - SEC Form 4  
 perchase seattle genetics   healthcare pharmaceuticals and biosciences biotechnology
Ameren
  few hours ago at Macroaxis
Filed for Walter Galvin
Filed transaction by Ameren Corp director. Grant, award or other acquisition pursuant to Rule 16b-3. Ameren Corporation insider trading alert for grant of common stock $.01 par value by Walter Galvin, the corporate stakeholder, on September 22, 2018. This event was filed by Ameren Corp with SEC on 2010-01-14. Statement of changes in beneficial ownership - SEC Form 4  
 grant ameren   utilities utilities - regulated electric diversified utilities
Regeneron Pharmaceuticals
  few hours ago at Macroaxis
Filed for Neil Stahl
Filed transaction by Regeneron Pharmaceuticals officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). Regeneron Pharmaceuticals insider trading alert for grant of non-qualified stock option (right to buy) by Neil Stahl, SVP Research & Devel Sciences, on September 22, 2018. This event was filed by Regeneron Pharmaceuticals with SEC on 2008-12-18. Statement of changes in beneficial ownership - SEC Form 4  
 grant regeneron pharmaceuticals   healthcare pharmaceuticals and biosciences biotechnology
Zoetis
  few hours ago at Macroaxis
Filed for Catherine Knupp
Filed transaction by Zoetis Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3. Zoetis insider trading alert for grant of phantom stock unit by Catherine Knupp, Executive Vice President, on September 22, 2018. This event was filed by Zoetis Inc with SEC on 2015-04-10. Statement of changes in beneficial ownership - SEC Form 4. Catherine Knupp is currently serves as president of randd and executive vp of Zoetis  
 grant zoetis   healthcare pharmaceuticals and biosciences drug manufacturers - specialty & generic
Vertex Pharmaceuticals
  few hours ago at Macroaxis
Filed for Jeffrey Leiden
Filed transaction by Vertex Pharmaceuticals In director. Unconventional Insider trading. Vertex Pharmaceuticals Incorporated insider trading alert for general transaction of common stock by Jeffrey Leiden, CEO President, on September 22, 2018. This event was filed by Vertex Pharmaceuticals In with SEC on 2013-12-12. Statement of changes in beneficial ownership - SEC Form 4. Jeffrey Leiden is currently serves as chairman of the board and presidentident, ceo of Vertex Pharmaceuticals  
 general transaction vertex pharmaceuticals   healthcare pharmaceuticals and biosciences biotechnology
SciClone Pharmaceuticals
  few hours ago at Macroaxis
Filed for Friedhelm Blobel
Filed transaction by Sciclone Pharmaceuticals director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. SciClone Pharmaceuticals insider trading alert for exercise of common stock by Friedhelm Blobel, President CEO, on September 22, 2018. This event was filed by Sciclone Pharmaceuticals with SEC on 2017-04-28. Statement of changes in beneficial ownership - SEC Form 4. Friedhelm Blobel is currently serves as ceo and president executive director and member of bus. devel. committee of SciClone Pharmaceuticals  
 exercise sciclone pharmaceuticals   healthcare pharmaceuticals and biosciences
Charles River Labora
  few hours ago at Macroaxis
Filed for James Foster
Filed transaction by Charles River Laboratorie director. Payment of exercise price or tax liability by delivering or withholding securities. Charles River Laboratories International insider trading alert for payment of common stock by James Foster, President and CEO, on September 22, 2018. This event was filed by Charles River Laboratorie with SEC on 2010-03-02. Statement of changes in beneficial ownership - SEC Form 4. James Foster is currently serves as chairman of the board and presidentident, ceo of Charles River Labora  
 payment charles river   healthcare diagnostics & research business services
Fluidigm
  few hours ago at Macroaxis
Filed for Levin Capital Strategies Lp
Filed transaction by Fluidigm Corp executive. Unconventional Insider trading. Fluidigm Corporation insider trading alert for general transaction of common stock by Levin Capital Strategies Lp, the corporate stakeholder, on September 22, 2018. This event was filed by Fluidigm Corp with SEC on 2018-09-13. Statement of changes in beneficial ownership - SEC Form 4  
 general transaction fluidigm   healthcare diagnostics & research measuring and control equipment

Share Stories

Syndicate Stories to major social sites

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Portfolio Anywhere
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Etf Screener
Evaluate and analyze market performance of ETFs against different fundamental indicators, sectors and families
Research ETFs
Insiders Directory
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders
Search macroaxis.com